Hoese & Co LLP
- SEC CIK
- 0001840268
- Latest filing
- Jul 14, 2026
LLY holding history
Eli Lilly & Co in every 13F filed by Hoese & Co LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LLY overviewAll 13F holders of LLYFull Q2 2026 holdings
- Shares (Q2 2026)
- 65
- Value
- $78.0K
- % of portfolio
- 0.1%
- Quarters held
- 20
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 65 | $78.0K | 0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 65 | $59.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 65 | $69.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 65 | $49.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 65 | $50.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 65 | $53.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 65 | $50.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 65 | $57.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 65 | $53.3K | <0.1% | +15+30.0% | Added | Holders |
| Q1 2024 | 50 | $37.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 50 | $29.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 50 | $26.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 50 | $23.4K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 50 | $15.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 50 | $19.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 50 | $16.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 50 | $16.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 50 | $14.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 50 | $14.0K | <0.1% | +50 | New | Holders |
| Q2 2021 | 0 | $0 | 0.0% | −240−100.0% | Sold out | Holders |
| Q1 2021 | 240 | $45.0K | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.